Display options
Cite
Jia YF, Choi Y, Ayers-Ringler JR, et al. Differential . Front Cell Neurosci. 2017;11:217doi: 10.3389/fncel.2017.00217.
Jia, Y. F., Choi, Y., Ayers-Ringler, J. R., Biernacka, J. M., Geske, J. R., Lindberg, D. R., McElroy, S. L., Frye, M. A., Choi, D. S., & Veldic, M. (2017). Differential . Frontiers in cellular neuroscience, 11217. https://doi.org/10.3389/fncel.2017.00217
Jia, Yun-Fang, et al. "Differential ." Frontiers in cellular neuroscience vol. 11 (2017): 217. doi: https://doi.org/10.3389/fncel.2017.00217
Jia YF, Choi Y, Ayers-Ringler JR, Biernacka JM, Geske JR, Lindberg DR, McElroy SL, Frye MA, Choi DS, Veldic M. Differential . Front Cell Neurosci. 2017 Jul 21;11:217. doi: 10.3389/fncel.2017.00217. eCollection 2017. PMID: 28785205; PMCID: PMC5520464.
Copy Download .nbib Format: NLM
Share it on

Front Cell Neurosci. 2017 Jul 21;11:217. doi: 10.3389/fncel.2017.00217. eCollection 2017.

Differential .

Frontiers in cellular neuroscience

Yun-Fang Jia, YuBin Choi, Jennifer R Ayers-Ringler, Joanna M Biernacka, Jennifer R Geske, Daniel R Lindberg, Susan L McElroy, Mark A Frye, Doo-Sup Choi, Marin Veldic

Affiliations

  1. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, RochesterMN, United States.
  2. Neurobiology of Disease Program, Mayo Graduate School, Mayo Clinic, RochesterMN, United States.
  3. Department of Psychiatry and Psychology, Mayo Clinic Depression Center, Mayo Clinic, RochesterMN, United States.
  4. Division of Biomedical Statistics and Informatics, Mayo Clinic, RochesterMN, United States.
  5. Lindner Center of HOPE, MasonOH, United States.
  6. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, CincinnatiOH, United States.

PMID: 28785205 PMCID: PMC5520464 DOI: 10.3389/fncel.2017.00217

Abstract

While downregulation of excitatory amino acid transporter 2 (EAAT2), the main transporter removing glutamate from the synapse, has been recognized in bipolar disorder (BD), the underlying mechanisms of downregulation have not been elucidated. BD is influenced by environmental factors, which may, via epigenetic modulation of gene expression, differentially affect illness presentation. This study thus focused on epigenetic DNA methylation regulation of

Keywords: SLC1A2 (EAAT2); addiction; biomarkers; bipolar disorder; glutamate; methylation

References

  1. Biochem Pharmacol. 2008 Jan 1;75(1):218-65 - PubMed
  2. Ann Neurol. 2004 Apr;55(4):469-77 - PubMed
  3. Gene. 2016 Sep 30;590(2):307-16 - PubMed
  4. Bipolar Disord. 2006 Dec;8(6):677-85 - PubMed
  5. World J Psychiatry. 2016 Mar 22;6(1):31-42 - PubMed
  6. Neuropsychopharmacology. 2012 Jun;37(7):1647-55 - PubMed
  7. Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):687-96 - PubMed
  8. Int J Neuropsychopharmacol. 2014 Aug;17(8):1167-76 - PubMed
  9. J Affect Disord. 2012 Jan;136(1-2):63-71 - PubMed
  10. J Psychiatr Res. 2011 Nov;45(11):1432-8 - PubMed
  11. J Psychiatr Res. 2011 May;45(5):588-95 - PubMed
  12. Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16356-61 - PubMed
  13. Neurosci Biobehav Rev. 2016 Sep;68:474-88 - PubMed
  14. Mol Psychiatry. 2007 Dec;12(12):1065-78 - PubMed
  15. J Clin Epidemiol. 2005 Jun;58(6):603-8 - PubMed
  16. Mol Biol Evol. 2014 Mar;31(3):594-604 - PubMed
  17. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1955-60 - PubMed
  18. Am J Psychiatry. 1995 Mar;152(3):365-72 - PubMed
  19. Gene. 2013 Feb 15;515(1):163-6 - PubMed
  20. J Clin Psychopharmacol. 2013 Dec;33(6):821-3 - PubMed
  21. Arterioscler Thromb Vasc Biol. 2004 May;24(5):982-7 - PubMed
  22. Clin Chim Acta. 2010 Jul 4;411(13-14):940-6 - PubMed
  23. Neuropsychopharmacology. 2015 Jan;40(1):141-53 - PubMed
  24. Genome Inform. 2004;15(2):287-95 - PubMed
  25. Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):576-81 - PubMed
  26. Methods Mol Biol. 2011;791:11-21 - PubMed
  27. Glia. 2007 May;55(7):663-74 - PubMed
  28. Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):619-628 - PubMed
  29. Nat Protoc. 2008;3(12):1903-8 - PubMed
  30. Int J Bipolar Disord. 2015 Dec;3(1):30 - PubMed
  31. J Affect Disord. 2013 Sep 25;150(3):981-6 - PubMed
  32. Epigenomics. 2012 Dec;4(6):605-21 - PubMed
  33. Schizophr Res. 2009 Jun;111(1-3):115-22 - PubMed
  34. Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):663-73 - PubMed
  35. J Affect Disord. 2010 Dec;127(1-3):230-40 - PubMed
  36. Eur Neuropsychopharmacol. 2008 Nov;18(11):794-802 - PubMed
  37. Mol Diagn Ther. 2012 Oct;16(5):303-9 - PubMed
  38. J Mol Biol. 2014 Oct 9;426(20):3389-412 - PubMed
  39. J Comp Neurol. 2005 Nov 7;492(1):78-89 - PubMed
  40. Glia. 2010 Feb;58(3):277-86 - PubMed
  41. Pharmaceuticals (Basel). 2012 Jan 18;5(1):94-113 - PubMed
  42. Trends Genet. 2012 Sep;28(9):427-35 - PubMed
  43. Mol Psychiatry. 2016 Mar;21(3):357-63 - PubMed
  44. Mol Cell Biol. 1987 Dec;7(12):4582-4 - PubMed
  45. Ultrastruct Pathol. 2009 Oct;33(5):197-208 - PubMed
  46. BMC Genet. 2016 Jan 25;17:27 - PubMed
  47. J Affect Disord. 2016 Jan 15;190:286-93 - PubMed
  48. Int J Neuropsychopharmacol. 2012 Oct;15(9):1217-28 - PubMed
  49. J Psychiatr Res. 2010 Apr;44(5):263-70 - PubMed
  50. Curr Drug Abuse Rev. 2010 Sep;3(3):163-74 - PubMed
  51. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):348-53 - PubMed
  52. Am J Med Genet B Neuropsychiatr Genet. 2011 Jul;156B(5):536-45 - PubMed
  53. Biol Psychiatry. 2010 Nov 1;68(9):785-94 - PubMed
  54. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:146-52 - PubMed
  55. J Exp Med. 2015 Mar 9;212(3):319-32 - PubMed
  56. Alcohol Clin Exp Res. 2013 Mar;37(3):417-24 - PubMed
  57. Mayo Clin Proc. 2013 Sep;88(9):952-62 - PubMed
  58. Clin Psychol Rev. 2016 Mar;44:125-139 - PubMed
  59. Prog Neuropsychopharmacol Biol Psychiatry. 1998 Jan;22(1):81-96 - PubMed
  60. Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2152-7 - PubMed

Publication Types